Drug Resistance in Tuberculous Lymphadenitis: Molecular Characterization

Table 1

Location and position of lymphadenopathy status of the study participant’s data () drowned from ALERT and St. Peter TB Specialized Hospital, Addis Ababa, Ethiopia 2020.

Variables	Clinically suspected TBLN (%)	Culture negative (%)	Culture positive (%)
Location of lymph node
Unilateral right-sided	89 (40.8%)	69 (78.4%)	19 (21.6%)
Unilateral left-sided	92 (42.2%)	68 (78.2%)	19 (21.8%)
Bilateral	36 (16.5%)	23 (65.7%)	12 (34.29%)
Generalized	1 (0.5%)	1 (100%)	0
Total	218 (100)	161 (76.3%)	50 (23.7%)
Position of lymph node
Anterior cervical	87 (39.9%)	65 (75.6%)	21 (24.4%)
Posterior cervical	55 (25.2%)	40 (74.1%)	14 (25.9%)
Supra clavicular	25 (11.5%)	17 (73.9%)	6 (26.1%)
Axillary	22 (10.1%)	13 (65%)	7 (35%)
Mandibular	9 (4.1%)	6 (75%)	2 (25%)
Inguinal	16 (7.3%)	16 (100%)	0
Occipital	2 (1.0%)	2 (100%)	0
Femoral	1 (0.5%)	1 (100%)	0
Chest	1 (0.5%)	1 (100%)	0
Total	218 (100)	161 (76.3%)	50 (23.7%)